$PJT

PJT Partners Inc. (PJT): Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

PJT Partners Inc. (PJT) filed an SEC Form 8-K — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers. 8-K false 0001626115 0001626115 2026-07-13 2026-07-13 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ————————— FORM 8-K ————————— CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event

Original reporting
Published Jul 16, 2026, 10:50 AM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jul 16, 2026, 11:01 AM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefCorporate actions
Primary signal
$PJT
Neutral
medium confidence
Mentioned
$PJT
Relevance
6/10
alphai data visualization · based on SEC EDGAR 8-K
Decision brief

The 30-second read

$PJTNeutralLow
01

Why it matters

The filing updates corporate governance and executive continuity expectations. It also clarifies compensation during the transition and equity retirement treatment, which can influence investor perceptions of incentive alignment.

02

Market read

This is a primary-source executive change disclosure with defined effective dates and transition compensation, but no new financial guidance.

03

What to watch

Investors may focus on the attached Exhibit 99.1 and the 2026 Proxy Statement for equity award treatment details, which could affect perceived retention and incentives.

Relevance 6/10Novelty 5/10Timing: today’s SEC 8-K filing, with CFO transition effective Oct 1, 2026

Background

PJT filed an 8-K (Item 5.02) announcing CFO Helen Meates’ planned step-down and naming Arun Kalra as CFO successor effective Oct 1, 2026.

Company-level read

Ticker impact

$PJTNeutralMedium confidence
Context

PJT disclosed CFO Helen Meates stepping down effective Oct 1, 2026, with Arun Kalra appointed as successor.

Expected impact

Likely limited immediate price reaction unless investors view the transition as disruptive; watch for follow-on disclosures in the attached exhibit and any proxy details.

Evidence & confidence

The 8-K is a primary-source executive change filing. It includes effective dates and compensation/retirement mechanics, but no earnings, guidance, or operational metrics that would directly reset valuation.

Market effects

Signals ongoing executive succession planning in investment banking and advisory firms, but no sector-wide policy or regulatory change is disclosed.

No direct regional market linkage beyond US-listed governance news.

No global deal, regulatory action, or cross-border operational change is described.

Counterpoint

The transition may be routine succession planning, with Kalra already serving as Director of Finance and having built the finance function, reducing disruption risk.

Key entities

  • PJT Partners Inc.

    US-listed advisory firm filing the 8-K regarding CFO transition and compensatory arrangements.

  • Helen Meates

    Chief Financial Officer stepping down effective Oct 1, 2026; remains in a non-executive role during transition.

  • Arun Kalra

    Appointed Chief Financial Officer effective Oct 1, 2026; currently Director of Finance.

Related articles

$PJTMed

PJT (NYSE:PJT) Reports Upbeat Q2 CY2026

PJT Partners (NYSE: PJT) reported Q2 CY2026 results. Revenue rose 19.5% year on year to $486.3 million, exceeding market expectations by 14.3%, according to the company. Non-GAAP EPS was $1.97, 25.6% above analysts’ consensus. The stock was reported flat at $168.80 after results.

$PJTMed

PJT Partners Inc. (PJT): Results of Operations and Financial Condition

PJT Partners Inc. (PJT) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 pjt-ex99_1.htm EX-99.1 EX-99.1 Exhibit 99.1 PJT Partners Inc. Reports Record Second Quarter and Six Months 2026 Results Second Quarter Overview > Record Second Quarter Revenues, Pretax Income and EPS – Revenues of $486 million, an increase of 20% from a year ago – GAAP

$PJTMed

PJT (PJT) Stock Is Up, What You Need To Know

PJT Partners shares rose about 2.7% after the firm acted as investment banker for STG Logistics in its successful Chapter 11 restructuring. UBS analyst Michael Brown raised PJT’s price target to $162 from $160 but kept a Neutral rating. After the initial move, PJT traded around $159.80, up 2.4% on the day.

$PJTMed

PJT (PJT) Stock Trades Up, Here Is Why

PJT Partners shares (NYSE: PJT) rose about 4.1% after the company was named financial adviser to Genel Energy in Genel’s recommended cash acquisition of Capricorn Energy, according to deal announcements. The stock traded around $162.63. The article notes PJT’s adjusted EPS of $2.55 and revenue of $535.2M in a prior quarter.

$ITWMed

Illinois Tool Works Authorizes $6 Bln Buyback

Illinois Tool Works (ITW) said its board authorized a new share repurchase program of up to $6 billion. The board also approved a 7% increase in its regular annual cash dividend to $6.88 per share, effective with the Q4 dividend of $1.72 payable Oct. 9, 2026. ITW closed at $296.66 on Friday.

$JNJMed

Money talcs: Why J&J offered $5.5bn to end cancer cases

Johnson & Johnson is offering $5.5 billion to settle most of more than 70,000 pending talc-related cancer lawsuits, according to the company. Claims allege ovarian cancer or mesothelioma linked to asbestos-contaminated talc. J&J denies wrongdoing and says cases lack merit. Prior orders include $966m (LA) and $1.5bn (Baltimore), with appeals planned.